title: Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity--a rebuttal.
authors.forename: S
authors.initials: S
authors.lastname: Sallah
authors.forename: M
authors.initials: M
authors.lastname: Isaksen
authors.forename: S
authors.initials: S
authors.lastname: Seremetis
authors.forename: L
authors.initials: L
authors.lastname: Payne Rojkjaer
mesh_terms: D001779:Blood Coagulation Factors / Q000009:adverse effects*; D015942:Factor VIIa / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D007262:Infusions, Intravenous; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects*; D013927:Thrombosis / Q000139:chemically induced* / Q000453:epidemiology
chemical_list: D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D015942:Factor VIIa